Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: OT: test....Anybody here?

I would consider a surprise in the quarterly to be a better than expected licensing fee paid by one of the signers - this is a long shot - and the market agrees judging from the current price action.

I also believe that "if" the J3 make us a great offer before the Markman, Patriot would settle before the Markman. This would also send a strong message to the industry IMO. (I also consider this a long shot.)

Share
New Message
Please login to post a reply